Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2010 of 5804
-
Real-world study examines caplacizumab for aTTP: better treatment on the horizon?
Disease control OngoingThe objective of this national, prospective, multi-centre observational study is to describe the prescription rational and practice in Germany, confirm the efficacy of caplacizumab in a real-world setting, and identify predicting factors in iTTP-patients with regard to persistent…
Sponsor: University of Cologne • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Can screening and online therapy during pregnancy prevent postpartum depression?
Symptom relief CompletedThis scale-up study aimed to explore the effectiveness of simultaneous screening and intervention of antenatal depression and anxiety in preventing postpartum depression and anxiety and how scale-up might be successfully achieved. The age was ≥18 years old pregnancy and capable o…
Phase: NA • Sponsor: Anhui Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
New mammogram technique could reduce unnecessary breast biopsies
Diagnosis OngoingThis clinical trial evaluates the added role of contrast-enhanced mammography (CEM), as well as imaging and blood biomarkers, for predicting the presence or absence of high-grade ductal carcinoma in situ (DCIS) or invasive cancer on pathology. Screening mammography is the mainsta…
Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 09:08 UTC
-
Kidney patients may not need long blood thinners after stents
Disease control Recruiting nowThe purpose of this prospective randomized clinical trial is to compare the clinical outcomes according to the duration of aspirin and clopidogrel or prasugrel with dual anti-platelet therapy after percutaneous coronary intervention in patients with advanced chronic kidney diseas…
Phase: NA • Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Testosterone shot may ease fatigue in young cancer survivors
Symptom relief Recruiting nowThe overall goal of this study is to evaluate the effect of a testosterone drug called Depo-Testosterone (or 'testosterone cypionate'), an FDA-approved drug for improving fatigue, sexual function, quality of life, body composition, muscle strength, and physical activity in young …
Phase: PHASE2 • Sponsor: Seattle Institute for Biomedical and Clinical Research • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Brain zaps and online therapy: a new combo for depression?
Symptom relief CompletedMajor Depressive Disorder (MDD) is a common mental health diagnosis. While there are many approaches to the treatment of MDD, current treatments of MDD often do not substantially reduce depressive symptoms among those in need of care. Prior research suggests that combining cognit…
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
AI may predict patient decline at home before it happens
Knowledge-focused CompletedThis is a retrospective observational study drawing on data from the Brigham and Women's Home Hospital database. Sociodemographic and clinic data from a training cohort were used to train a machine learning algorithm to predict patient deterioration throughout a patient's admissi…
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
New hope for myelofibrosis anemia: experimental drug enters human trials
Disease control OngoingThis Phase 1/2, open-label, dose-finding study is intended to evaluate the safety and tolerability, PK, PD, and efficacy of INCB000928 administered as monotherapy or in combination with ruxolitinib in participants with MF who are transfusion-dependent or presenting with symptomat…
Phase: PHASE1, PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Spit test could spot esophagus condition before it turns cancerous
Diagnosis Recruiting nowThis is a longitudinal cohort study to assess the impact of repeated sampling of an oral microbiome signature for Barrett's esophagus (BE). Potential participants will be identified through chart review of patients who have had an endoscopy in the past three years.
Sponsor: Columbia University • Aim: Diagnosis
Last updated Jun 27, 2026 12:32 UTC
-
Experimental pancreatic cancer combo trial halted early
Disease control TerminatedThis study is a two stage study consisting of a dose escalation phase Ib and a phase II study which include subjects with previously-treated, advanced pancreatic adenocarcinoma. Dose Limiting Toxicities (DLTs) and maximum tolerated dose (MTD) of APG1387 in combination with nab-pa…
Phase: PHASE1, PHASE2 • Sponsor: Ascentage Pharma Group Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Could a two-vein embolization trick turn inoperable liver tumors into operable ones?
Knowledge-focused Recruiting nowThe DRAGON registry aims to collect data on combined portal and hepatic vein embolization (PVE/HVE) for liver tumors, a technique expected to enhance liver regeneration compared to standard PVE. This collaborative registry focuses on identifying associations between baseline clin…
Sponsor: Maastricht University Medical Center • Aim: Knowledge-focused
Last updated Jul 23, 2026 00:00 UTC
-
Phone coaching helps pregnant women avoid excess weight gain and diabetes
Prevention CompletedHealthy for Two, Healthy for You (H42/H4U) is an innovative evidence-based pregnancy/postpartum health coach intervention that is remotely-delivered (phone coaching using motivational interviewing, web-based platform, mobile phone behavioral tracking). The aim of this randomized …
Phase: NA • Sponsor: Johns Hopkins University • Aim: Prevention
Last updated Jul 04, 2026 00:00 UTC
-
100,000 volunteers join digital brain health study to catch dementia early
Knowledge-focused ENROLLING_BY_INVITATIONThe study is carried out as part of the GR2021 Priority project "Healthy Brains for life (Age 20-99): Digitally-enhanced personalized medicine study ANANEOS" and code numbered GR-00546 and it will look at the decentralized and remote assessment of the symptoms of preclinical stag…
Sponsor: Greece 2021 Committee • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Can a computer program fight frailty? new study tests digital coach for seniors
Disease control CompletedThe study aims to evaluate the feasibility and effectiveness of using SAIF (an end-to-end System for Assessment and Intervention of Frailty) to reduce the risk and delay the progress of physical frailty.
Phase: NA • Sponsor: Tan Tock Seng Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Monthly HIV prevention pill trial halted Mid-Study
Prevention TerminatedThe main purpose of the study is to evaluate the safety and tolerability of oral Islatravir (ISL) once monthly (QM) as Preexposure Prophylaxis (PrEP) in cisgender men who have sex with men (MSM) and transgender women (TGW) who have sex with men and who are at high risk of HIV-1 i…
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Prevention
Last updated Jun 27, 2026 12:29 UTC
-
New drug hope for rare joint tumor patients who Can't have surgery
Disease control CompletedThis phase 2, multicenter, two-part, open-label, single-arm study will be conducted in Japan and will evaluate the safety, tolerability, pharmacokinetics (PK), and efficacy of pexidartinib in adult participants with symptomatic tenosynovial giant cell tumor (TGCT) associated with…
Phase: PHASE2 • Sponsor: Daiichi Sankyo Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Sanofi mRNA vaccine trial ends early – what we know
⭐️ VACCINE ⭐️ TerminatedThe primary objectives of the study are: * To describe the safety profile of all participants in each age group and each study intervention group up to 12 months post-last dose. * To describe the neutralizing antibody profile at Day 1, Day 22, and Day 36 of each study interventi…
Phase: PHASE1, PHASE2 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 26, 2026 15:56 UTC
-
AI eye check could catch blood pressure damage early
Diagnosis CompletedThe current study is aimed at estimating the diagnostic effectiveness of a developed convolutional neural network (CNN) "RetinAIcheck" in grading the severity of hypertensive retinopathy in patients of the Russian population. The training data set was obtained from an open sourc…
Sponsor: I.M. Sechenov First Moscow State Medical University • Aim: Diagnosis
Last updated Jun 27, 2026 11:01 UTC
-
New softer cement could reduce repeat spine fractures
Disease control OngoingThe overall purpose of conducting this study is to evaluate the safety and efficacy of V-Flex and V-Steady for augmentation of osteoporotic vertebral compression fractures and to verify that adding a cement softener into a PMMA bone cement is comparable to a PMMA bone cement alon…
Phase: NA • Sponsor: Inossia AB • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Your plate may fight psoriatic arthritis: diet study tests food as medicine
Disease control CompletedThe purpose of this study is to learn whether changing diet impacts psoriatic arthritis (PsA).
Phase: NA • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC